We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 21, 2020

Poor Overall Survival of Patients With MBC and Subtype Conversion

Diagnostics (Basel, Switzerland)


Additional Info

Diagnostics (Basel, Switzerland)
Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of Principle
Diagnostics (Basel) 2020 Jun 04;[EPub Ahead of Print], S Stefanovic, TM Deutsch, R Wirtz, A Hartkopf, P Sinn, M Kohler, J Hofmann, S Bankovic, K Vassilev, M Sütterlin, A Schneeweiss, M Wallwiener

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading